A few recent papers have performed genome-wide mapping of PR binding sites in breast cancer cells [74], [75], [76] confirming that the receptor binds more frequently in intra- and inter- genic regions than in the promoters of target genes in agreement with earlier observations [25], [59]. Here, PGR is linked to breast carcinoma.